AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Q32 Bio Inc. Director's Dealing 2023

Jan 20, 2023

34891_dirs_2023-01-20_db25763b-42ee-47be-81fb-bf8efaa3c122.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: Homology Medicines, Inc. (FIXX)
CIK: 0001661998
Period of Report: 2022-03-02

Reporting Person: Blum Michael Lee (Chief Commercial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3280	Direct

Footnotes

F1: The Reporting Person over-reported his Table I holdings on his original Form 3 filing and also over-reported his Table I holdings on the subsequent two Form 4s filed by the Reporting person on January 4, 2023 and January 11, 2023.